-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's Intraday Session
Share
Listen to the news

Gainers

  • Mobile-health Network (NASDAQ:MNDR) stock rose 370.0% to $4.0 during Monday's regular session. The market value of their outstanding shares is at $1.0 million.
  • XORTX Therapeutics (NASDAQ:XRTX) shares moved upwards by 24.11% to $1.75. The market value of their outstanding shares is at $2.5 million.
  • CollPlant Biotechnologies (NASDAQ:CLGN) shares rose 21.79% to $4.28. The market value of their outstanding shares is at $6.6 million.
  • Processa Pharma (NASDAQ:PCSA) shares moved upwards by 21.05% to $1.84. The company's market cap stands at $4.2 million.
  • Apollomics (NASDAQ:APLM) stock increased by 20.93% to $26.0. The market value of their outstanding shares is at $62.6 million.
  • Greenland Mines (NASDAQ:GRML) shares moved upwards by 20.11% to $6.21. The company's market cap stands at $39.3 million.

Losers

  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock declined by 37.1% to $0.09 during Monday's regular session.
  • Contineum Therapeutics (NASDAQ:CTNM) stock fell 31.28% to $9.2. The company's market cap stands at $503.3 million.
  • Quantum Cyber (NASDAQ:QUCY) stock fell 23.34% to $1.03. The company's market cap stands at $113.4 million.
  • CervoMed (NASDAQ:CRVO) stock decreased by 20.94% to $2.55. The market value of their outstanding shares is at $48.6 million.
  • Pomdoctor (NASDAQ:POM) shares fell 20.78% to $0.61. The company's market cap stands at $7.1 million.
  • SCWorx (NASDAQ:WORX) stock fell 20.65% to $2.96. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending